Fidelity Advisor Overseas Fund OCSE:NOVO B Holdings History
Fidelity Advisor Overseas Fund's Novo Nordisk AS Holding Summary
As of 2025-04-30, FIDELITY ADVISOR SERIES VIII held 44,400.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr2.97 Mil. This investment constitutes 0.74% of their stock portfolio, and FIDELITY ADVISOR SERIES VIII now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2023Q1. And since then Fidelity Advisor Overseas Fund has made 4 purchases of OCSE:NOVO B, at an average price of kr487.28, for a total of 114,900.00 shares. In addition, there have been 5 sales at an average price of kr589.06 for 70,500.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr423.90, Fidelity Advisor Overseas Fund's estimated gain on his OCSE:NOVO B holdings is kr4.36 Mil, reflecting a 7.79% gain to date.
Fidelity Advisor Overseas Fund OCSE:NOVO B (kr423.90) Holding Chart
Fidelity Advisor Overseas Fund OCSE:NOVO B (kr423.90) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price kr-/Share | ||
Shares Sold | 0 | Average Price kr-/Share | ||
Current Price kr0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1